| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRD ATP7A SLC37A3 HCN3 GRIA3 SLC7A6 CHRNB2 SLC7A9 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SLC22A8 SCN1A SCN2A PKD1 SCN8A SCN9A SV2C ABCG2 SLC7A10 GABRA2 GABRA5 GABRA6 | 4.24e-08 | 1180 | 131 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRD ATP7A SLC37A3 HCN3 GRIA3 APOB SLC7A6 CHRNB2 SLC7A9 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SLC22A8 SCN1A SCN2A PKD1 SCN8A SCN9A SV2C ABCG2 SLC7A10 GABRA2 GABRA5 GABRA6 | 6.28e-08 | 1289 | 131 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | procollagen glucosyltransferase activity | 2.76e-07 | 3 | 131 | 3 | GO:0033823 | |
| GeneOntologyMolecularFunction | procollagen-lysine 5-dioxygenase activity | 2.76e-07 | 3 | 131 | 3 | GO:0008475 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 PIEZO2 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 3.51e-07 | 459 | 131 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRD ATP7A SLC37A3 HCN3 GRIA3 SLC6A2 CACNG8 CACNA2D4 SLC46A3 SLC13A4 SLC22A8 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 5.28e-07 | 758 | 131 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.63e-07 | 26 | 131 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRD ATP7A HCN3 GRIA3 CHRNB2 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 1.04e-06 | 793 | 131 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | peptidyl-lysine 5-dioxygenase activity | 1.10e-06 | 4 | 131 | 3 | GO:0070815 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.68e-06 | 14 | 131 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | channel activity | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 PIEZO2 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 1.88e-06 | 525 | 131 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 PIEZO2 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 1.93e-06 | 526 | 131 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.96e-06 | 57 | 131 | 6 | GO:1904315 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 PIEZO2 SCN1A SCN2A GABRA2 GABRA5 GABRA6 | 2.11e-06 | 334 | 131 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.66e-06 | 60 | 131 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.27e-06 | 65 | 131 | 6 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.27e-06 | 65 | 131 | 6 | GO:0022824 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 6.35e-06 | 19 | 131 | 4 | GO:0004890 | |
| GeneOntologyMolecularFunction | carbohydrate binding | PLOD3 MANBA CLEC1A NOMO1 GANAB NOMO2 GYS2 PKD1 PLOD1 PLOD2 NOMO3 | 6.42e-06 | 310 | 131 | 11 | GO:0030246 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.88e-06 | 75 | 131 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.15e-05 | 77 | 131 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 1.18e-05 | 22 | 131 | 4 | GO:0046527 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.18e-05 | 22 | 131 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7A HCN3 GRIA3 SLC6A2 CACNG8 CACNA2D4 SLC46A3 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A | 1.20e-05 | 465 | 131 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 PIEZO2 SCN1A SCN2A PKD1 SCN8A SCN9A | 1.66e-05 | 343 | 131 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.74e-05 | 171 | 131 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.28e-05 | 52 | 131 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.36e-05 | 26 | 131 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 2.76e-05 | 27 | 131 | 4 | GO:0030548 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP7A HCN3 GRIA3 CHRNB2 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A | 3.09e-05 | 664 | 131 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 3.21e-05 | 28 | 131 | 4 | GO:0099602 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 4.38e-05 | 11 | 131 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.11e-05 | 100 | 131 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.88e-05 | 37 | 131 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.10e-04 | 38 | 131 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.37e-04 | 171 | 131 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.10e-04 | 18 | 131 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP7A HCN3 GRIA3 SLC6A2 CACNG8 CACNA2D4 SLC46A3 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A | 2.49e-04 | 627 | 131 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.87e-04 | 193 | 131 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 2.90e-04 | 20 | 131 | 3 | GO:0031418 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.26e-04 | 197 | 131 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 4.07e-04 | 95 | 131 | 5 | GO:0048029 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.05e-04 | 24 | 131 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 1.17e-03 | 8 | 131 | 2 | GO:0005375 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRD XCR1 ERBB2 GALR3 CLEC1A GRIA3 PTCH1 F2R ADGRG4 CHRNB2 TAS2R5 PROKR2 GPR62 PKD1 ADGRF5 TAS2R31 GABRA2 GABRA5 GABRA6 | 1.33e-03 | 1353 | 131 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.41e-03 | 125 | 131 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.42e-03 | 34 | 131 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 1.86e-03 | 10 | 131 | 2 | GO:0042799 | |
| GeneOntologyMolecularFunction | lipase activity | 2.18e-03 | 138 | 131 | 5 | GO:0016298 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.18e-03 | 83 | 131 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.48e-03 | 86 | 131 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 2.71e-03 | 211 | 131 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.95e-03 | 288 | 131 | 7 | GO:0016757 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 3.18e-03 | 13 | 131 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.21e-03 | 151 | 131 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.24e-03 | 293 | 131 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.43e-03 | 296 | 131 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | palmitoyl hydrolase activity | 3.69e-03 | 14 | 131 | 2 | GO:0098599 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 3.79e-03 | 157 | 131 | 5 | GO:0052689 | |
| GeneOntologyMolecularFunction | glucosidase activity | 4.24e-03 | 15 | 131 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7A SLC37A3 SLC7A6 SLC7A9 SLC6A2 SLC46A3 SLC13A4 SLC22A8 ABCG2 | 4.26e-03 | 477 | 131 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.32e-03 | 50 | 131 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.74e-03 | 103 | 131 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 4.83e-03 | 16 | 131 | 2 | GO:0047372 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 4.88e-03 | 238 | 131 | 6 | GO:0016747 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 5.08e-03 | 105 | 131 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.45e-03 | 17 | 131 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | histone H4 methyltransferase activity | 5.45e-03 | 17 | 131 | 2 | GO:0140939 | |
| GeneOntologyMolecularFunction | phospholipase activity | 6.77e-03 | 114 | 131 | 4 | GO:0004620 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.04e-03 | 182 | 131 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.36e-03 | 184 | 131 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 7.51e-03 | 20 | 131 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 7.53e-03 | 61 | 131 | 3 | GO:1901682 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.09e-06 | 63 | 132 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | DPAGT1 PLOD3 ATP7A MANBA HGSNAT IDS GANAB ALG9 PLOD1 PLOD2 DSE SOAT1 C1GALT1C1L | 3.99e-06 | 430 | 132 | 13 | GO:0009100 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 7.77e-06 | 112 | 132 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRD XCR1 ATP7A HCN3 GRIA3 F2R CHRNB2 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 8.15e-06 | 1115 | 132 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 1.83e-05 | 25 | 132 | 4 | GO:0045737 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 2.09e-05 | 9 | 132 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine hydroxylation | 2.09e-05 | 9 | 132 | 3 | GO:0017185 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRD XCR1 ATP7A SLC37A3 HCN3 F2R SLC6A2 CACNG8 CACNA2D4 SLC46A3 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 2.58e-05 | 1017 | 132 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 2.91e-05 | 28 | 132 | 4 | GO:1904031 | |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 2.98e-05 | 10 | 132 | 3 | GO:0045759 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 3.86e-05 | 30 | 132 | 4 | GO:1904862 | |
| GeneOntologyBiologicalProcess | hydroxylysine biosynthetic process | 4.06e-05 | 2 | 132 | 2 | GO:0046947 | |
| GeneOntologyBiologicalProcess | hydroxylysine metabolic process | 4.06e-05 | 2 | 132 | 2 | GO:0046946 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 5.01e-05 | 32 | 132 | 4 | GO:0099505 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRD XCR1 ATP7A HCN3 GRIA3 F2R CHRNB2 SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SLC22A8 SCN1A SCN2A PKD1 SCN8A SCN9A GABRA2 GABRA5 GABRA6 | 5.88e-05 | 1374 | 132 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRD HCN3 GRIA3 CHRNB2 PIEZO2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A GABRA2 GABRA5 GABRA6 | 6.29e-05 | 559 | 132 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 7.19e-05 | 35 | 132 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 8.05e-05 | 36 | 132 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | CDS2 LIPF CAT APOB SERINC2 PIGU AWAT2 CHPT1 SYNJ2 ABHD12 ABHD16A | 1.01e-04 | 429 | 132 | 11 | GO:0046486 |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.13e-04 | 74 | 132 | 5 | GO:0051932 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.29e-04 | 121 | 132 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monoacylglycerol metabolic process | 1.35e-04 | 16 | 132 | 3 | GO:0046462 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.62e-04 | 180 | 132 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.62e-04 | 180 | 132 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.94e-04 | 247 | 132 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.25e-04 | 134 | 132 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | phosphatidylserine catabolic process | 2.42e-04 | 4 | 132 | 2 | GO:0006660 | |
| GeneOntologyBiologicalProcess | negative regulation of neuronal action potential | 2.42e-04 | 4 | 132 | 2 | GO:1904456 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid biosynthetic process | 3.61e-04 | 22 | 132 | 3 | GO:0009067 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.90e-04 | 208 | 132 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 4.94e-04 | 357 | 132 | 9 | GO:0009101 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 5.08e-04 | 156 | 132 | 6 | GO:0006639 | |
| GeneOntologyBiologicalProcess | phosphatidylserine metabolic process | 5.32e-04 | 25 | 132 | 3 | GO:0006658 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 5.32e-04 | 25 | 132 | 3 | GO:0021692 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 5.44e-04 | 158 | 132 | 6 | GO:0006638 | |
| GeneOntologyBiologicalProcess | walking behavior | 5.92e-04 | 60 | 132 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | response to odorant | 6.00e-04 | 6 | 132 | 2 | GO:1990834 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.71e-04 | 62 | 132 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | nerve development | 6.83e-04 | 109 | 132 | 5 | GO:0021675 | |
| GeneOntologyBiologicalProcess | protein hydroxylation | 7.47e-04 | 28 | 132 | 3 | GO:0018126 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 8.02e-04 | 65 | 132 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | DPAGT1 PLOD3 ATP7A MANBA ACSM1 HGSNAT IDS PIGU GANAB PPT2 ALG9 ABCG2 ELOVL6 PLOD1 PLOD2 DSE SOAT1 C1GALT1C1L | 8.25e-04 | 1226 | 132 | 18 | GO:1901135 |
| GeneOntologyBiologicalProcess | monoacylglycerol catabolic process | 8.36e-04 | 7 | 132 | 2 | GO:0052651 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 8.36e-04 | 7 | 132 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 8.74e-04 | 173 | 132 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRD CNTN4 GALR3 MYO5B GRIA3 F2R CHRNB2 SLC6A2 CACNG8 CNTNAP2 SV2C SLC7A10 GABRA2 GABRA5 GABRA6 | 9.17e-04 | 931 | 132 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRD CNTN4 GALR3 MYO5B GRIA3 F2R CHRNB2 SLC6A2 CACNG8 CNTNAP2 SV2C SLC7A10 GABRA2 GABRA5 GABRA6 | 9.17e-04 | 931 | 132 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 9.28e-04 | 175 | 132 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRD CNTN4 GALR3 MYO5B GRIA3 F2R CHRNB2 SLC6A2 CACNG8 CNTNAP2 SV2C SLC7A10 GABRA2 GABRA5 GABRA6 | 1.00e-03 | 939 | 132 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 1.01e-03 | 31 | 132 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | XCR1 ATP7A HCN3 F2R SLC6A2 CACNG8 CACNA2D4 SLC46A3 PIEZO2 SLC13A4 SCN1A SCN2A PKD1 SCN8A SCN9A | 1.03e-03 | 942 | 132 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | axonogenesis | CNTN4 ERBB2 MYO5B LAMA3 LAMC3 PTCH1 CHRNB2 ATL1 CNTN6 CNTNAP2 NTN1 | 1.05e-03 | 566 | 132 | 11 | GO:0007409 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 SCN1A SCN2A PKD1 SCN8A CNTNAP2 SCN9A CATSPERG ABHD12 GABRA2 GABRA5 GABRA6 | 3.02e-10 | 378 | 133 | 17 | GO:0034702 |
| GeneOntologyCellularComponent | presynaptic membrane | ERBB2 GRIA3 CHRNB2 CNTN6 SLC6A2 SCN1A SCN2A SCN8A CNTNAP2 C1QA GABRA2 GABRA5 GABRA6 | 2.54e-08 | 277 | 133 | 13 | GO:0042734 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 SCN1A SCN2A PKD1 SCN8A CNTNAP2 SCN9A CATSPERG ABHD12 GABRA2 GABRA5 GABRA6 | 3.86e-08 | 523 | 133 | 17 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRD HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 SCN1A SCN2A PKD1 SCN8A CNTNAP2 SCN9A CATSPERG ABHD12 GABRA2 GABRA5 GABRA6 | 7.96e-08 | 550 | 133 | 17 | GO:1990351 |
| GeneOntologyCellularComponent | synaptic membrane | GABRD ERBB2 GRIA3 F2R CHRNB2 CNTN6 SLC6A2 CACNG8 SCN1A SCN2A SCN8A CNTNAP2 C1QA FAIM2 GABRA2 GABRA5 GABRA6 | 1.82e-07 | 583 | 133 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | cation channel complex | HCN3 CACNG8 CACNA2D4 SCN1A SCN2A PKD1 SCN8A CNTNAP2 SCN9A CATSPERG | 2.69e-06 | 235 | 133 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.50e-06 | 17 | 133 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | cell projection membrane | ERBB2 ATP7A TSPEAR PTCH1 SLC7A9 CACNG8 SYNJ2 PKD1 CNTNAP2 ABCG2 GABRA2 GABRA5 GABRA6 | 3.86e-06 | 431 | 133 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 5.64e-06 | 19 | 133 | 4 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 8.62e-06 | 21 | 133 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRD ERBB2 GRIA3 F2R CHRNB2 CACNG8 SCN8A C1QA FAIM2 GABRA2 GABRA5 GABRA6 | 1.11e-05 | 405 | 133 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.06e-05 | 9 | 133 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | axon initial segment | 3.29e-05 | 29 | 133 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.29e-05 | 29 | 133 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | lysosomal lumen | 3.86e-05 | 98 | 133 | 6 | GO:0043202 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPAGT1 TLCD3B PLOD3 SLC37A3 DNAJC16 CDS2 APOB PIGU AWAT2 ATL1 NOMO1 CHPT1 NOMO2 ALG9 ELOVL6 PLOD1 PLOD2 ABHD12 DSE NOMO3 SOAT1 | 6.69e-05 | 1293 | 133 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPAGT1 TLCD3B PLOD3 SLC37A3 DNAJC16 CDS2 APOB PIGU AWAT2 ATL1 NOMO1 CHPT1 NOMO2 ALG9 ELOVL6 PLOD1 PLOD2 ABHD12 DSE NOMO3 SOAT1 | 7.15e-05 | 1299 | 133 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 8.71e-05 | 14 | 133 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPAGT1 TLCD3B PLOD3 SLC37A3 DNAJC16 CDS2 APOB PIGU AWAT2 ATL1 NOMO1 CHPT1 NOMO2 ALG9 ELOVL6 PLOD1 PLOD2 ABHD12 DSE NOMO3 SOAT1 | 9.67e-05 | 1327 | 133 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | plasma membrane protein complex | TRAV12-2 ERBB2 TRAV2 HCN3 GRIA3 CHRNB2 CACNG8 CACNA2D4 SCN1A SCN2A SCN8A CNTNAP2 SCN9A CATSPERG ABHD12 | 1.44e-04 | 785 | 133 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | presynapse | ERBB2 HCN3 GRIA3 CHRNB2 CNTN6 SLC6A2 SYNJ2 SCN1A SCN2A SCN8A CNTNAP2 C1QA SV2C GABRA2 GABRA5 GABRA6 | 1.64e-04 | 886 | 133 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | axon | GABRD CNTN4 ATP7A HCN3 GRIA3 PTCH1 ATL1 CNTN6 SLC6A2 SYNJ2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A GABRA2 | 1.75e-04 | 891 | 133 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | neuron projection membrane | 1.78e-04 | 82 | 133 | 5 | GO:0032589 | |
| GeneOntologyCellularComponent | membrane protein complex | TRAV12-2 GABRD ERBB2 TRAV2 HCN3 GRIA3 PIGU CHRNB2 CACNG8 CACNA2D4 SCN1A SCN2A PKD1 SCN8A CNTNAP2 SCN9A ELOVL6 CATSPERG ABHD12 GABRA2 GABRA5 GABRA6 | 1.90e-04 | 1498 | 133 | 22 | GO:0098796 |
| GeneOntologyCellularComponent | node of Ranvier | 2.65e-04 | 20 | 133 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.07e-04 | 201 | 133 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | receptor complex | TRAV12-2 GABRD ERBB2 TRAV2 GRIA3 CHRNB2 CACNG8 GPR62 ABHD12 GABRA2 GABRA5 GABRA6 | 3.43e-04 | 581 | 133 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | leading edge membrane | 3.99e-04 | 210 | 133 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | dendrite membrane | 4.45e-04 | 56 | 133 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.76e-04 | 57 | 133 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | neuronal cell body | GABRD ATP7A MYO5B HCN3 GRIA3 APOB SLC6A2 SCN1A SCN8A CNTNAP2 SLC7A10 GABRA2 GABRA5 GABRA6 | 8.86e-04 | 835 | 133 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 9.02e-04 | 30 | 133 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | vacuolar lumen | 9.84e-04 | 178 | 133 | 6 | GO:0005775 | |
| GeneOntologyCellularComponent | dendrite | GABRD ATP7A MYO5B HCN3 GRIA3 PTCH1 CACNG8 SCN8A CNTNAP2 ABHD12 SLC7A10 GABRA2 GABRA5 GABRA6 | 1.15e-03 | 858 | 133 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRD ATP7A MYO5B HCN3 GRIA3 PTCH1 CACNG8 SCN8A CNTNAP2 ABHD12 SLC7A10 GABRA2 GABRA5 GABRA6 | 1.17e-03 | 860 | 133 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | calcium channel complex | 1.21e-03 | 73 | 133 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.55e-03 | 78 | 133 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRD ATP7A MYO5B HCN3 GRIA3 APOB PTCH1 SLC6A2 CACNG8 SCN1A SCN8A CNTNAP2 ABHD12 SLC7A10 GABRA2 GABRA5 GABRA6 | 2.05e-03 | 1228 | 133 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | postsynapse | GABRD ERBB2 ATP7A MYO5B GRIA3 F2R CHRNB2 CACNG8 SCN8A CNTNAP2 C1QA FAIM2 GABRA2 GABRA5 GABRA6 | 2.09e-03 | 1018 | 133 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | cell body | GABRD ATP7A MYO5B HCN3 GRIA3 APOB SLC6A2 SCN1A SCN8A CNTNAP2 SLC7A10 GABRA2 GABRA5 GABRA6 | 2.41e-03 | 929 | 133 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | main axon | 2.52e-03 | 89 | 133 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.58e-03 | 43 | 133 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 2.58e-03 | 43 | 133 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.94e-03 | 45 | 133 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.13e-03 | 46 | 133 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cell body membrane | 3.33e-03 | 47 | 133 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ERBB2 ATP7A MANBA MYO5B HGSNAT GRIA3 APOB PTCH1 CACNG8 MALRD1 MS4A3 GPR62 NBEAL2 PKD1 SV2C DSE GABRA2 | 3.89e-03 | 1307 | 133 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 3.97e-03 | 50 | 133 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | vesicle membrane | ERBB2 ATP7A MANBA MYO5B HGSNAT GRIA3 APOB PTCH1 CACNG8 MALRD1 MS4A3 GPR62 NBEAL2 PKD1 SV2C DSE GABRA2 | 4.46e-03 | 1325 | 133 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | excitatory synapse | 4.88e-03 | 107 | 133 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | paranode region of axon | 5.13e-03 | 17 | 133 | 2 | GO:0033270 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 7.16e-03 | 350 | 133 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 7.91e-03 | 64 | 133 | 3 | GO:0005791 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 8.54e-03 | 22 | 133 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | membrane raft | 8.54e-03 | 362 | 133 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 8.79e-03 | 364 | 133 | 7 | GO:0098857 | |
| HumanPheno | Focal automatism seizure | 5.65e-06 | 12 | 55 | 4 | HP:0032898 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 8.09e-06 | 13 | 55 | 4 | HP:0007058 | |
| HumanPheno | Limited knee extension | 8.22e-06 | 27 | 55 | 5 | HP:0003066 | |
| HumanPheno | Focal motor seizure | 8.73e-06 | 131 | 55 | 9 | HP:0011153 | |
| HumanPheno | Decreased palmar creases | 1.17e-05 | 5 | 55 | 3 | HP:0006184 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.52e-05 | 15 | 55 | 4 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 2.01e-05 | 16 | 55 | 4 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 2.01e-05 | 16 | 55 | 4 | HP:0011172 | |
| HumanPheno | Interictal epileptiform activity | GABRD DPAGT1 ATP7A GRIA3 CHRNB2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A VARS1 GABRA2 GABRA5 | 2.36e-05 | 319 | 55 | 13 | HP:0011182 |
| HumanPheno | Atypical absence status epilepticus | 2.61e-05 | 17 | 55 | 4 | HP:0011151 | |
| HumanPheno | Interictal EEG abnormality | GABRD DPAGT1 ATP7A GRIA3 CHRNB2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A VARS1 GABRA2 GABRA5 | 2.87e-05 | 325 | 55 | 13 | HP:0025373 |
| HumanPheno | Limitation of knee mobility | 3.09e-05 | 35 | 55 | 5 | HP:0010501 | |
| HumanPheno | Visually-induced seizure | 3.33e-05 | 18 | 55 | 4 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 3.33e-05 | 18 | 55 | 4 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 5.19e-05 | 20 | 55 | 4 | HP:0032671 | |
| HumanPheno | Status epilepticus | GABRD GRIA3 SCN1A SCN2A SCN8A CNTNAP2 SCN9A VARS1 GABRA2 GABRA5 | 5.82e-05 | 207 | 55 | 10 | HP:0002133 |
| HumanPheno | Talipes valgus | 6.35e-05 | 21 | 55 | 4 | HP:0004684 | |
| HumanPheno | Photosensitive myoclonic seizure | 6.42e-05 | 8 | 55 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 6.42e-05 | 8 | 55 | 3 | HP:0200048 | |
| HumanPheno | Reflex seizure | 7.70e-05 | 22 | 55 | 4 | HP:0020207 | |
| HumanPheno | Poor fine motor coordination | 8.52e-05 | 69 | 55 | 6 | HP:0007010 | |
| HumanPheno | Tibial torsion | 9.25e-05 | 23 | 55 | 4 | HP:0100694 | |
| HumanPheno | Focal hemiclonic seizure | 1.30e-04 | 25 | 55 | 4 | HP:0006813 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 1.78e-04 | 27 | 55 | 4 | HP:0031475 | |
| HumanPheno | Polycystic liver disease | 1.85e-04 | 11 | 55 | 3 | HP:0006557 | |
| HumanPheno | Limited neck range of motion | 1.85e-04 | 11 | 55 | 3 | HP:0000466 | |
| HumanPheno | Focal aware seizure | 2.06e-04 | 28 | 55 | 4 | HP:0002349 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 2.15e-04 | 52 | 55 | 5 | HP:0025190 | |
| HumanPheno | Focal-onset seizure | GABRD DPAGT1 GRIA3 LAMC3 CHRNB2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A VARS1 GABRA5 | 2.43e-04 | 346 | 55 | 12 | HP:0007359 |
| HumanPheno | Epilepsia partialis continua | 2.45e-04 | 12 | 55 | 3 | HP:0012847 | |
| HumanPheno | Poor motor coordination | 2.72e-04 | 85 | 55 | 6 | HP:0002275 | |
| HumanPheno | Cortical dysplasia | 3.07e-04 | 56 | 55 | 5 | HP:0002539 | |
| HumanPheno | Abnormal knee physiology | 3.09e-04 | 87 | 55 | 6 | HP:0034670 | |
| HumanPheno | Uric acid nephrolithiasis | 3.16e-04 | 13 | 55 | 3 | HP:0000791 | |
| HumanPheno | EEG with abnormally slow frequencies | 3.29e-04 | 88 | 55 | 6 | HP:0011203 | |
| HumanPheno | Abnormal curvature of the vertebral column | GABRD DPAGT1 SAMD9 PLOD3 ATP7A NSD2 TMEM216 HGSNAT GRIA3 IDS PTCH1 PIGU ATL1 PIEZO2 SCN1A ALG9 SCN2A SCN9A KATNIP MMP13 MMP14 PLOD1 PLOD2 ABHD16A DSE | 3.58e-04 | 1219 | 55 | 25 | HP:0010674 |
| HumanPheno | Arachnoid cyst | 3.62e-04 | 58 | 55 | 5 | HP:0100702 | |
| HumanPheno | Focal impaired awareness seizure | 3.63e-04 | 126 | 55 | 7 | HP:0002384 | |
| HumanPheno | Abnormal arachnoid mater morphology | 3.92e-04 | 59 | 55 | 5 | HP:0100700 | |
| HumanPheno | Obsessive-compulsive trait | 3.95e-04 | 33 | 55 | 4 | HP:0008770 | |
| HumanPheno | Flank pain | 3.99e-04 | 14 | 55 | 3 | HP:0030157 | |
| HumanPheno | Abnormal vertebral morphology | PLOD3 ATP7A NSD2 HGSNAT IDS PTCH1 PIEZO2 NTN1 KATNIP MMP13 MMP14 PLOD1 PLOD2 DSE | 4.43e-04 | 483 | 55 | 14 | HP:0003468 |
| HumanPheno | Generalized clonic seizure | 4.44e-04 | 34 | 55 | 4 | HP:0011169 | |
| HumanPheno | Calcaneovalgus deformity | 4.44e-04 | 34 | 55 | 4 | HP:0001848 | |
| HumanPheno | EEG abnormality | GABRD DPAGT1 ATP7A NSD2 GRIA3 LAMC3 CHRNB2 SCN1A SCN2A SCN8A CNTNAP2 SCN9A VARS1 GABRA2 GABRA5 | 4.89e-04 | 548 | 55 | 15 | HP:0002353 |
| HumanPheno | Facial tics | 4.94e-04 | 15 | 55 | 3 | HP:0011468 | |
| HumanPheno | Deformed tarsal bones | 4.97e-04 | 35 | 55 | 4 | HP:0008119 | |
| HumanPheno | EEG with generalized epileptiform discharges | GABRD DPAGT1 ATP7A SCN1A SCN2A SCN8A CNTNAP2 SCN9A GABRA2 GABRA5 | 5.19e-04 | 270 | 55 | 10 | HP:0011198 |
| HumanPheno | Limitation of joint mobility | GABRD PLOD3 ATP7A HGSNAT PERP IDS PIEZO2 SCN1A SCN2A SCN9A MMP13 PLOD1 PLOD2 | 5.19e-04 | 432 | 55 | 13 | HP:0001376 |
| HumanPheno | Pancreatic cysts | 5.55e-04 | 36 | 55 | 4 | HP:0001737 | |
| HumanPheno | Calcium oxalate nephrolithiasis | 6.04e-04 | 16 | 55 | 3 | HP:0008672 | |
| HumanPheno | Global brain atrophy | 6.30e-04 | 138 | 55 | 7 | HP:0002283 | |
| HumanPheno | Pituitary growth hormone cell adenoma | 7.28e-04 | 17 | 55 | 3 | HP:0011760 | |
| HumanPheno | Focal motor status epilepticus | 7.28e-04 | 17 | 55 | 3 | HP:0032663 | |
| HumanPheno | Aplasia/Hypoplasia of the palmar creases | 7.28e-04 | 17 | 55 | 3 | HP:0010488 | |
| HumanPheno | Calcium nephrolithiasis | 8.67e-04 | 18 | 55 | 3 | HP:0004724 | |
| HumanPheno | Cystic liver disease | 9.16e-04 | 41 | 55 | 4 | HP:0006706 | |
| HumanPheno | Abnormal tibia morphology | 9.38e-04 | 107 | 55 | 6 | HP:0002992 | |
| HumanPheno | Impulsivity | 9.94e-04 | 149 | 55 | 7 | HP:0100710 | |
| HumanPheno | Focal clonic seizure | 1.00e-03 | 42 | 55 | 4 | HP:0002266 | |
| HumanPheno | Abnormal form of the vertebral bodies | PLOD3 ATP7A NSD2 HGSNAT PTCH1 PIEZO2 KATNIP MMP13 MMP14 PLOD1 PLOD2 | 1.01e-03 | 348 | 55 | 11 | HP:0003312 |
| MousePheno | dilated pulmonary alveolar duct | 1.45e-05 | 7 | 106 | 3 | MP:0010908 | |
| MousePheno | seizures | ASNSD1 GABRD ATP7A GRIA3 CHRNB2 SCN1A SCN8A CNTNAP2 SCN9A C1QA FAIM2 SLC7A10 | 1.77e-05 | 360 | 106 | 12 | MP:0002064 |
| MousePheno | abnormal cutaneous collagen fibril morphology | 4.79e-05 | 27 | 106 | 4 | MP:0008438 | |
| MousePheno | abnormal behavioral response to anesthetic | 8.87e-05 | 12 | 106 | 3 | MP:0009777 | |
| MousePheno | abnormal pulmonary alveolar duct morphology | 1.15e-04 | 13 | 106 | 3 | MP:0002271 | |
| MousePheno | abnormal telencephalon morphology | ATP7A MANBA HGSNAT PTCH1 CNTN6 CACNG8 PPT2 PROKR2 SCN1A PKD1 CNTNAP2 C1QA NCOA7 NTN1 KATNIP DNAH5 GABRA5 | 1.22e-04 | 812 | 106 | 17 | MP:0000787 |
| MousePheno | increased anxiety-related response | 1.24e-04 | 311 | 106 | 10 | MP:0001363 | |
| MousePheno | absence seizures | 1.36e-04 | 35 | 106 | 4 | MP:0003216 | |
| MousePheno | postnatal lethality, complete penetrance | ATP7A NSD2 TMEM216 PERP LAMA3 PTCH1 SCN1A SCN2A PKD1 SCN8A NTN1 MMP14 | 1.37e-04 | 445 | 106 | 12 | MP:0011085 |
| MousePheno | abnormal seizure response to inducing agent | 1.44e-04 | 201 | 106 | 8 | MP:0009357 | |
| MousePheno | postnatal lethality | GABRD ATP7A NSD2 TMEM216 PERP LAMA3 APOB PTCH1 PROKR2 SCN1A SCN2A PKD1 SCN8A SCN9A NTN1 PAX5 MMP14 DNAH5 SLC7A10 GABRA2 | 1.63e-04 | 1084 | 106 | 20 | MP:0002082 |
| MousePheno | abnormal cerebral hemisphere morphology | ATP7A MANBA HGSNAT CNTN6 CACNG8 PPT2 SCN1A CNTNAP2 C1QA NCOA7 NTN1 KATNIP DNAH5 GABRA5 | 1.68e-04 | 599 | 106 | 14 | MP:0008540 |
| MousePheno | wide ribs | 1.70e-04 | 3 | 106 | 2 | MP:0004676 | |
| MousePheno | nonconvulsive seizures | 2.31e-04 | 40 | 106 | 4 | MP:0000948 | |
| Domain | Na_trans_cytopl | 3.22e-08 | 6 | 129 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 3.22e-08 | 6 | 129 | 4 | IPR024583 | |
| Domain | Procol_lys_dOase | 3.22e-07 | 3 | 129 | 3 | IPR001006 | |
| Domain | LYS_HYDROXYLASE | 3.22e-07 | 3 | 129 | 3 | PS01325 | |
| Domain | Na_channel_asu | 4.42e-07 | 10 | 129 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 4.42e-07 | 10 | 129 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 4.42e-07 | 10 | 129 | 4 | PF06512 | |
| Domain | Spy1 | 6.90e-07 | 11 | 129 | 4 | PF11357 | |
| Domain | Speedy | 6.90e-07 | 11 | 129 | 4 | IPR020984 | |
| Domain | DUF2012 | 1.28e-06 | 4 | 129 | 3 | PF09430 | |
| Domain | DUF2012 | 1.28e-06 | 4 | 129 | 3 | IPR019008 | |
| Domain | GABAAa_rcpt | 6.34e-06 | 6 | 129 | 3 | IPR001390 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.42e-05 | 45 | 129 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 1.59e-05 | 46 | 129 | 5 | PF02932 | |
| Domain | GABAA/Glycine_rcpt | 1.74e-05 | 23 | 129 | 4 | IPR006028 | |
| Domain | Carb-bd-like_fold | 1.76e-05 | 8 | 129 | 3 | IPR013784 | |
| Domain | Neurotrans-gated_channel_TM | 1.77e-05 | 47 | 129 | 5 | IPR006029 | |
| Domain | - | 1.77e-05 | 47 | 129 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 1.77e-05 | 47 | 129 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.77e-05 | 47 | 129 | 5 | PS00236 | |
| Domain | Neur_channel | 1.77e-05 | 47 | 129 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.77e-05 | 47 | 129 | 5 | IPR006202 | |
| Domain | CarboxyPept_regulatory_dom | 8.75e-05 | 13 | 129 | 3 | IPR014766 | |
| Domain | AA_permease_2 | 8.75e-05 | 13 | 129 | 3 | PF13520 | |
| Domain | - | 8.75e-05 | 13 | 129 | 3 | 2.60.40.1120 | |
| Domain | AA/rel_permease1 | 8.75e-05 | 13 | 129 | 3 | IPR002293 | |
| Domain | Ion_channel_UNC-93 | 1.41e-04 | 3 | 129 | 2 | IPR010291 | |
| Domain | UNC-93 | 1.41e-04 | 3 | 129 | 2 | PF05978 | |
| Domain | P4Hc | 1.69e-04 | 16 | 129 | 3 | SM00702 | |
| Domain | Laminin_N | 1.69e-04 | 16 | 129 | 3 | IPR008211 | |
| Domain | LamNT | 1.69e-04 | 16 | 129 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.69e-04 | 16 | 129 | 3 | PS51117 | |
| Domain | Laminin_N | 1.69e-04 | 16 | 129 | 3 | PF00055 | |
| Domain | Pro_4_hyd_alph | 1.69e-04 | 16 | 129 | 3 | IPR006620 | |
| Domain | CarboxyPept-like_regulatory | 2.04e-04 | 17 | 129 | 3 | IPR008969 | |
| Domain | IQ | 2.45e-04 | 81 | 129 | 5 | SM00015 | |
| Domain | 2OG-FeII_Oxy | 2.88e-04 | 19 | 129 | 3 | PF03171 | |
| Domain | MFS_dom | 3.37e-04 | 134 | 129 | 6 | IPR020846 | |
| Domain | FE2OG_OXY | 3.91e-04 | 21 | 129 | 3 | PS51471 | |
| Domain | IQ_motif_EF-hand-BS | 4.00e-04 | 90 | 129 | 5 | IPR000048 | |
| Domain | AA-permease/SLC12A_dom | 4.50e-04 | 22 | 129 | 3 | IPR004841 | |
| Domain | AA_permease | 4.50e-04 | 22 | 129 | 3 | PF00324 | |
| Domain | IQ | 4.65e-04 | 93 | 129 | 5 | PS50096 | |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | SM00570 | |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | PS51215 | |
| Domain | AWS_dom | 4.67e-04 | 5 | 129 | 2 | IPR006560 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 5.15e-04 | 23 | 129 | 3 | IPR005123 | |
| Domain | Channel_four-helix_dom | 6.46e-04 | 57 | 129 | 4 | IPR027359 | |
| Domain | - | 6.46e-04 | 57 | 129 | 4 | 1.20.120.350 | |
| Domain | ConA-like_dom | 8.26e-04 | 219 | 129 | 7 | IPR013320 | |
| Domain | EGF_LAM_2 | 1.14e-03 | 30 | 129 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.14e-03 | 30 | 129 | 3 | PS01248 | |
| Domain | Ion_trans_dom | 1.17e-03 | 114 | 129 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.17e-03 | 114 | 129 | 5 | PF00520 | |
| Domain | Abhydrolase_1 | 1.26e-03 | 31 | 129 | 3 | PF00561 | |
| Domain | PH-BEACH_dom | 1.29e-03 | 8 | 129 | 2 | IPR023362 | |
| Domain | - | 1.29e-03 | 8 | 129 | 2 | 2.30.29.40 | |
| Domain | LAMININ_IVA | 1.29e-03 | 8 | 129 | 2 | PS51115 | |
| Domain | Laminin_B | 1.29e-03 | 8 | 129 | 2 | PF00052 | |
| Domain | PH_BEACH | 1.29e-03 | 8 | 129 | 2 | PS51783 | |
| Domain | LamB | 1.29e-03 | 8 | 129 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.29e-03 | 8 | 129 | 2 | IPR000034 | |
| Domain | IQ | 1.48e-03 | 71 | 129 | 4 | PF00612 | |
| Domain | AB_hydrolase_1 | 1.51e-03 | 33 | 129 | 3 | IPR000073 | |
| Domain | - | 1.64e-03 | 73 | 129 | 4 | 2.60.120.260 | |
| Domain | GPS | 1.65e-03 | 34 | 129 | 3 | SM00303 | |
| Domain | BEACH | 1.65e-03 | 9 | 129 | 2 | PS50197 | |
| Domain | Beach | 1.65e-03 | 9 | 129 | 2 | PF02138 | |
| Domain | - | 1.65e-03 | 9 | 129 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.65e-03 | 9 | 129 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.65e-03 | 9 | 129 | 2 | IPR000409 | |
| Domain | EGF_Lam | 1.79e-03 | 35 | 129 | 3 | SM00180 | |
| Domain | GPS | 1.79e-03 | 35 | 129 | 3 | PF01825 | |
| Domain | Laminin_EGF | 1.79e-03 | 35 | 129 | 3 | PF00053 | |
| Domain | GPS | 1.95e-03 | 36 | 129 | 3 | PS50221 | |
| Domain | MFS_1 | 1.99e-03 | 77 | 129 | 4 | PF07690 | |
| Domain | MFS | 1.99e-03 | 77 | 129 | 4 | IPR011701 | |
| Domain | GPS | 2.11e-03 | 37 | 129 | 3 | IPR000203 | |
| Domain | Laminin_EGF | 2.28e-03 | 38 | 129 | 3 | IPR002049 | |
| Domain | SET | 2.83e-03 | 41 | 129 | 3 | PF00856 | |
| Domain | LamG | 3.47e-03 | 44 | 129 | 3 | SM00282 | |
| Domain | SET | 3.93e-03 | 46 | 129 | 3 | SM00317 | |
| Domain | Galactose-bd-like | 4.10e-03 | 94 | 129 | 4 | IPR008979 | |
| Domain | Pept_M10A_Zn_BS | 4.69e-03 | 15 | 129 | 2 | IPR021158 | |
| Domain | SET_dom | 4.98e-03 | 50 | 129 | 3 | IPR001214 | |
| Domain | SET | 4.98e-03 | 50 | 129 | 3 | PS50280 | |
| Domain | Post-SET_dom | 5.33e-03 | 16 | 129 | 2 | IPR003616 | |
| Domain | PostSET | 5.33e-03 | 16 | 129 | 2 | SM00508 | |
| Domain | POST_SET | 5.33e-03 | 16 | 129 | 2 | PS50868 | |
| Domain | Glycoside_hydrolase_SF | 5.86e-03 | 53 | 129 | 3 | IPR017853 | |
| Domain | Hemopexin_CS | 6.02e-03 | 17 | 129 | 2 | IPR018486 | |
| Domain | MFS | 6.70e-03 | 108 | 129 | 4 | PS50850 | |
| Domain | Pept_M10A_stromelysin-type | 6.74e-03 | 18 | 129 | 2 | IPR016293 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRD CNTN4 GRIA3 CNTN6 SLC6A2 CACNG8 SCN1A SCN2A SCN8A CNTNAP2 SCN9A CNTN3 GABRA2 GABRA5 | 1.55e-07 | 367 | 95 | 14 | M48346 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.18e-06 | 32 | 95 | 5 | M27455 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 1.10e-05 | 44 | 95 | 5 | M13720 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 2.42e-05 | 9 | 95 | 3 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 3.44e-05 | 10 | 95 | 3 | M477 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 5.30e-05 | 31 | 95 | 4 | M39369 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.30e-05 | 31 | 95 | 4 | M877 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.20e-04 | 38 | 95 | 4 | M39854 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 2.54e-04 | 46 | 95 | 4 | M46450 | |
| Pathway | WP_GPCRS_ORPHAN | 2.66e-04 | 19 | 95 | 3 | MM15991 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 2.77e-04 | 47 | 95 | 4 | M42524 | |
| Pathway | WP_RETT_SYNDROME | 3.00e-04 | 48 | 95 | 4 | M39759 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.50e-04 | 90 | 95 | 5 | M631 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.22e-04 | 144 | 95 | 6 | MM14501 | |
| Pathway | REACTOME_CIPROFLOXACIN_ADME | 4.43e-04 | 5 | 95 | 2 | M46440 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 4.94e-04 | 272 | 95 | 8 | M13380 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 5.42e-04 | 24 | 95 | 3 | MM17215 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 6.12e-04 | 25 | 95 | 3 | M4974 | |
| Pathway | WP_DRAVET_SYNDROME | 8.60e-04 | 28 | 95 | 3 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION | 9.23e-04 | 7 | 95 | 2 | M47608 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.14e-09 | 6 | 134 | 4 | 23652591 | |
| Pubmed | 7.31e-09 | 7 | 134 | 4 | 17021187 | ||
| Pubmed | 2.62e-08 | 9 | 134 | 4 | 16382098 | ||
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 2.62e-08 | 9 | 134 | 4 | 36272447 | |
| Pubmed | GABRD GALR3 GRIA3 CHRNB2 CNTN6 SLC6A2 CNTNAP2 CNTN3 GABRA2 GABRA5 GABRA6 | 2.63e-08 | 300 | 134 | 11 | 19086053 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 36011023 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 10429951 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 11896059 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 11956192 | ||
| Pubmed | Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. | 5.59e-08 | 3 | 134 | 3 | 10934207 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 9582318 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16996725 | ||
| Pubmed | The genes encoding mouse lysyl hydroxylase isoforms map to chromosomes 4,5, and 9. | 5.59e-08 | 3 | 134 | 3 | 11130984 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 32845893 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 28518218 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 31446433 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 17928448 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 5.59e-08 | 3 | 134 | 3 | 25576386 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 1.47e-07 | 13 | 134 | 4 | 15611625 | |
| Pubmed | 1.47e-07 | 13 | 134 | 4 | 15123669 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 17537961 | ||
| Pubmed | Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. | 2.23e-07 | 4 | 134 | 3 | 16467571 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 35031483 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 29578003 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 21156207 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.23e-07 | 4 | 134 | 3 | 31833031 | |
| Pubmed | PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43. | 2.23e-07 | 4 | 134 | 3 | 33483598 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 9267806 | ||
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 4.82e-07 | 17 | 134 | 4 | 15574121 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 8812438 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 27539848 | ||
| Pubmed | 7.48e-07 | 81 | 134 | 6 | 22723691 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 20457185 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 15063128 | ||
| Pubmed | 1.20e-06 | 21 | 134 | 4 | 25708312 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.94e-06 | 7 | 134 | 3 | 25818041 | |
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 20301424 | ||
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 1.94e-06 | 7 | 134 | 3 | 15377789 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.09e-06 | 8 | 134 | 3 | 15257293 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ERBB2 PLOD3 MANBA DNAJC16 LAMC3 PIGU PLBD2 NOMO1 GANAB CHPT1 NOMO2 ALG9 PLOD1 PLOD2 ABHD12 DSE SOAT1 | 3.97e-06 | 1201 | 134 | 17 | 35696571 |
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 15901826 | ||
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 21464123 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 4.62e-06 | 9 | 134 | 3 | 36261522 | |
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 15746173 | ||
| Pubmed | Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. | 4.62e-06 | 9 | 134 | 3 | 21752829 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 6.11e-06 | 31 | 134 | 4 | 19136429 | |
| Pubmed | 6.11e-06 | 31 | 134 | 4 | 19736351 | ||
| Pubmed | Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome. | 6.97e-06 | 32 | 134 | 4 | 36920550 | |
| Pubmed | 7.90e-06 | 33 | 134 | 4 | 30783098 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 9.02e-06 | 11 | 134 | 3 | 9924185 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 9.02e-06 | 11 | 134 | 3 | 32820719 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 9.02e-06 | 11 | 134 | 3 | 38894703 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 1.18e-05 | 130 | 134 | 6 | 19874574 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.20e-05 | 12 | 134 | 3 | 30175250 | |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 1.20e-05 | 12 | 134 | 3 | 16701205 | |
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 14557543 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.47e-05 | 2 | 134 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.47e-05 | 2 | 134 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.47e-05 | 2 | 134 | 2 | 10827969 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19694741 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 35348308 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 34304093 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.47e-05 | 2 | 134 | 2 | 1317301 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26783471 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31439038 | ||
| Pubmed | Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. | 1.47e-05 | 2 | 134 | 2 | 25580854 | |
| Pubmed | The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. | 1.47e-05 | 2 | 134 | 2 | 17525114 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.47e-05 | 2 | 134 | 2 | 15249644 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.47e-05 | 2 | 134 | 2 | 27174182 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 36469977 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18601978 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26446222 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.47e-05 | 2 | 134 | 2 | 19465131 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18480294 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26134650 | ||
| Pubmed | Hydrogen peroxide increases GABAA receptor-mediated tonic current in hippocampal neurons. | 1.47e-05 | 2 | 134 | 2 | 25100596 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.47e-05 | 2 | 134 | 2 | 23735284 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 32462874 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 29649454 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 10737763 | ||
| Pubmed | Cloning and characterization of a third human lysyl hydroxylase isoform. | 1.47e-05 | 2 | 134 | 2 | 9724729 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11334715 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 8663255 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9060628 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 33096315 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21228184 | ||
| Pubmed | Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. | 1.47e-05 | 2 | 134 | 2 | 21048709 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.47e-05 | 2 | 134 | 2 | 9460924 | |
| Pubmed | Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy. | 1.47e-05 | 2 | 134 | 2 | 34083510 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 1.47e-05 | 2 | 134 | 2 | 17805013 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 27768696 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26311622 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 33411788 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22610965 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 34086081 | ||
| Pubmed | Persistent Nav1.6 current at axon initial segments tunes spike timing of cerebellar granule cells. | 1.47e-05 | 2 | 134 | 2 | 20173079 | |
| Pubmed | Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus? | 1.47e-05 | 2 | 134 | 2 | 18256262 | |
| Interaction | TCTN3 interactions | PLOD3 DNAJC16 CDS2 PTCH1 PIGU GANAB CHPT1 ALG9 PLOD1 ABHD12 SOAT1 | 8.84e-06 | 334 | 127 | 11 | int:TCTN3 |
| Interaction | SCN4B interactions | 1.34e-05 | 8 | 127 | 3 | int:SCN4B | |
| Interaction | EPHA10 interactions | 1.73e-05 | 86 | 127 | 6 | int:EPHA10 | |
| Interaction | COL21A1 interactions | 2.00e-05 | 9 | 127 | 3 | int:COL21A1 | |
| Interaction | COL9A3 interactions | 2.84e-05 | 10 | 127 | 3 | int:COL9A3 | |
| Interaction | CALR3 interactions | 3.28e-05 | 142 | 127 | 7 | int:CALR3 | |
| Interaction | COL2A1 interactions | 5.20e-05 | 64 | 127 | 5 | int:COL2A1 | |
| Cytoband | 16p12.3 | 1.33e-04 | 34 | 133 | 3 | 16p12.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.19e-08 | 9 | 87 | 4 | 1203 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.40e-07 | 12 | 87 | 4 | 756 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.83e-06 | 19 | 87 | 4 | 563 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.78e-04 | 34 | 87 | 3 | 487 | |
| GeneFamily | Solute carriers | SLC37A3 SLC7A6 SLC7A9 SLC6A2 SLC46A3 SLC13A4 SLC22A8 SLC7A10 | 6.28e-04 | 395 | 87 | 8 | 752 |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.06e-04 | 9 | 87 | 2 | 1230 | |
| GeneFamily | Laminin subunits | 1.46e-03 | 12 | 87 | 2 | 626 | |
| GeneFamily | PWWP domain containing | 4.97e-03 | 22 | 87 | 2 | 1147 | |
| GeneFamily | Abhydrolase domain containing | 4.97e-03 | 22 | 87 | 2 | 4 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 5.90e-03 | 24 | 87 | 2 | 891 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.90e-03 | 26 | 87 | 2 | 253 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.61e-03 | 161 | 87 | 4 | 593 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CNTN4 TLCD3B DNAJC16 HCN3 LAMA3 IDS ATL1 CACNG8 PIEZO2 RGS6 SCN1A SCN2A SCN8A CNTNAP2 SCN9A NCOA7 SV2C PAX5 CATSPERG GABRA2 | 5.49e-07 | 1106 | 130 | 20 | M39071 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPAGT1 ERBB2 PLOD3 MFSD11 CDS2 HGSNAT PTCH1 SLC7A6 PIGU TRIM11 GANAB ALG9 ABHD12 VARS1 SOAT1 | 1.52e-06 | 681 | 130 | 15 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPAGT1 ERBB2 PLOD3 MFSD11 CDS2 HGSNAT PTCH1 SLC7A6 PIGU TRIM11 GANAB ALG9 ABHD12 VARS1 SOAT1 | 2.25e-06 | 703 | 130 | 15 | MM1055 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL | 7.23e-06 | 54 | 130 | 5 | M45797 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | CNTN4 TLCD3B GRIA3 CACNG8 RGS6 SCN2A SCN8A CNTNAP2 SCN9A SV2C FAIM2 GABRA2 | 9.90e-06 | 513 | 130 | 12 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | CNTN4 TLCD3B HCN3 ATL1 SCN8A CNTNAP2 SCN9A SV2C FAIM2 GABRA5 | 2.53e-05 | 389 | 130 | 10 | M39073 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | CLEC1A IDS SLC6A2 SLC13A4 RGS6 CHPT1 ADGRF5 C1QTNF2 PAX5 SLC7A10 PRDM6 | 3.50e-05 | 491 | 130 | 11 | MM455 |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN | 3.67e-05 | 124 | 130 | 6 | M470 | |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP | 4.12e-05 | 77 | 130 | 5 | M1992 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | GABRD LAMC3 SERINC2 PGAP6 CHRNB2 SLC6A2 KL SCN8A SLC7A10 GABRA5 | 6.86e-05 | 438 | 130 | 10 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | GABRD LAMC3 SERINC2 PGAP6 CHRNB2 SLC6A2 KL SCN8A SLC7A10 GABRA5 | 7.12e-05 | 440 | 130 | 10 | MM832 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.35e-07 | 173 | 126 | 9 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.59e-06 | 279 | 126 | 10 | gudmap_kidney_adult_RenalCortexMixed_Std_k2_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_1000 | MANBA ACSM1 PERP CAT APOB PGAP6 SLC7A9 KL SLC22A8 CHPT1 GPR137B ABCG2 | 1.28e-05 | 441 | 126 | 12 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | MANBA ACSM1 PERP CAT APOB PGAP6 NSD3 SLC7A9 KL RGS6 SLC22A8 CHPT1 SCN2A GPR137B ADGRF5 ABCG2 | 1.51e-05 | 778 | 126 | 16 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | MANBA ACSM1 PERP CAT PBLD APOB PGAP6 SLC7A9 KL SLC22A8 CHPT1 GYS2 SCN2A GPR137B ADGRF5 ABCG2 | 2.09e-05 | 799 | 126 | 16 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | MYO5B ACSM1 PERP GRIA3 PBLD SLC7A9 KL SLC22A8 SCN8A GPR137B NCOA7 | 2.09e-05 | 389 | 126 | 11 | gudmap_developingKidney_e15.5_Proximal Tubules_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_500 | 3.65e-05 | 104 | 126 | 6 | gudmap_developingKidney_e15.5_early proxim tubul_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | MANBA MYO5B ACSM1 PERP GRIA3 PBLD ZFC3H1 SLC7A9 KL SLC22A8 CHPT1 NBEAL2 SCN8A GPR137B NCOA7 | 4.41e-05 | 758 | 126 | 15 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.55e-05 | 280 | 126 | 9 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k5 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 6.92e-05 | 72 | 126 | 5 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 7.39e-05 | 73 | 126 | 5 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | OMA1 HGSNAT GRIA3 CAT SERINC2 IDS PGAP6 SLC46A3 MB21D2 SLC22A8 PKD1 NTN1 KATNIP MMP14 TMEM26 PLOD2 SLC7A10 ABHD16A CNOT4 | 9.20e-05 | 1208 | 126 | 19 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CNTN4 ERBB2 ATP7A MYO5B GRIA3 PTCH1 CNTN6 PROKR2 SCN2A ADGRF5 MMP14 PLOD2 FAIM2 DSE SOAT1 | 1.17e-04 | 827 | 126 | 15 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | MANBA ACSM1 PERP CAT PBLD APOB PGAP6 SLC7A9 KL SLC22A8 CHPT1 GYS2 GPR137B ADGRF5 ABCG2 | 1.81e-04 | 861 | 126 | 15 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | MANBA MYO5B ACSM1 PERP PBLD APOB SLC7A9 KL PPT2 SLC22A8 CHPT1 NBEAL2 GPR137B C1QTNF2 | 2.34e-04 | 784 | 126 | 14 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_500 | 2.51e-04 | 21 | 126 | 3 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k2_500 | |
| CoexpressionAtlas | cerebral cortex | GABRD TLCD3B GRIA3 IDS CHRNB2 ATL1 CACNG8 RGS6 PROKR2 GPR62 SCN1A SCN2A SCN8A CNTNAP2 SV2C CNTN3 FAIM2 SLC7A10 GABRA2 GABRA5 | 2.80e-04 | 1428 | 126 | 20 | cerebral cortex |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-08 | 185 | 130 | 8 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-08 | 185 | 130 | 8 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-08 | 188 | 130 | 8 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-08 | 188 | 130 | 8 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-07 | 145 | 130 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 168 | 130 | 7 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 180 | 130 | 7 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 184 | 130 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 191 | 130 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-06 | 196 | 130 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-06 | 197 | 130 | 7 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-06 | 198 | 130 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-06 | 198 | 130 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-06 | 198 | 130 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-06 | 161 | 130 | 6 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.19e-06 | 162 | 130 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.42e-06 | 166 | 130 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 167 | 130 | 6 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.01e-05 | 168 | 130 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 168 | 130 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 172 | 130 | 6 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 172 | 130 | 6 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 174 | 130 | 6 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 176 | 130 | 6 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 177 | 130 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 178 | 130 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 178 | 130 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 180 | 130 | 6 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 130 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 3d7dd193a0826cc7a4e454a29236a16c315e5965 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.91e-05 | 188 | 130 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | wk_15-18-Epithelial-PNS-PCP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.97e-05 | 189 | 130 | 6 | 22c927d2691b867fbdee1fbee042a6d3f7eadd7d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 189 | 130 | 6 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 189 | 130 | 6 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 190 | 130 | 6 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | fa45042d30f9cfeed10e23270a78f18551219cfa | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | ab511ea9e09216a965b3ae5a94f8c3c1ae33d944 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 193 | 130 | 6 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 195 | 130 | 6 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 130 | 6 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | CF-Myeloid-Monocyte_Macrophage|CF / Disease state, Lineage and Cell class | 2.63e-05 | 199 | 130 | 6 | bf95eacb31a4a847350f9d6e95ca76c6b730c400 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.63e-05 | 199 | 130 | 6 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.70e-05 | 200 | 130 | 6 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.70e-05 | 200 | 130 | 6 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 2.70e-05 | 200 | 130 | 6 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.70e-05 | 200 | 130 | 6 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 127 | 130 | 5 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.78e-05 | 135 | 130 | 5 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 153 | 130 | 5 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.21e-05 | 155 | 130 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-05 | 157 | 130 | 5 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | Basal_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 158 | 130 | 5 | dd069a822e9698e6dddc155d9a5b52383f7879d5 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 159 | 130 | 5 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 159 | 130 | 5 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 160 | 130 | 5 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 162 | 130 | 5 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 164 | 130 | 5 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 164 | 130 | 5 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 165 | 130 | 5 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 165 | 130 | 5 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 166 | 130 | 5 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 166 | 130 | 5 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 167 | 130 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 167 | 130 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-04 | 168 | 130 | 5 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 169 | 130 | 5 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-04 | 169 | 130 | 5 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 169 | 130 | 5 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 170 | 130 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| Computational | Neurotransmitter (GABA) receptor. | 2.53e-06 | 15 | 73 | 4 | MODULE_215 | |
| Computational | Ion channels. | 3.05e-05 | 27 | 73 | 4 | MODULE_214 | |
| Computational | Ion channels. | 1.08e-04 | 70 | 73 | 5 | MODULE_316 | |
| Computational | Genes in the cancer module 141. | 1.58e-04 | 16 | 73 | 3 | MODULE_141 | |
| Computational | Genes in the cancer module 478. | 2.69e-04 | 19 | 73 | 3 | MODULE_478 | |
| Drug | sodium | GABRD ERVK-6 ERBB2 GRIA3 CAT SLC7A6 PLBD2 CHRNB2 NOMO1 SLC7A9 SLC6A2 CACNA2D4 SLC13A4 SLC22A8 SCN2A PKD1 CNTNAP2 SCN9A SLC7A10 GABRA2 GABRA5 GABRA6 | 1.40e-08 | 944 | 128 | 22 | CID000000923 |
| Drug | secobarbital | 5.65e-08 | 37 | 128 | 6 | CID000005193 | |
| Drug | Nitrazepam | 3.05e-07 | 11 | 128 | 4 | DB01595 | |
| Drug | gabapentin | GABRD IGFLR1 CACNG8 CACNA2D4 PKD1 SCN9A GABRA2 GABRA5 GABRA6 | 4.95e-07 | 169 | 128 | 9 | CID000003446 |
| Drug | riluzole | 6.32e-07 | 174 | 128 | 9 | CID000005070 | |
| Drug | tetradotoxin | GABRD GALR3 GRIA3 PTCH1 CHRNB2 CACNA2D4 SCN2A SCN8A SCN9A PLOD1 GABRA2 GABRA5 GABRA6 | 9.13e-07 | 428 | 128 | 13 | CID000020382 |
| Drug | dehydro-histidinohydroxymerodesmosine | 1.72e-06 | 5 | 128 | 3 | CID003037599 | |
| Drug | dihydroxyaflavinine | 2.14e-06 | 17 | 128 | 4 | CID000156857 | |
| Drug | DMCM | 2.25e-06 | 38 | 128 | 5 | CID000104999 | |
| Drug | procaine | 2.50e-06 | 153 | 128 | 8 | CID000004914 | |
| Drug | felbamate | 2.74e-06 | 70 | 128 | 6 | CID000003331 | |
| Drug | Gabrene | 2.92e-06 | 40 | 128 | 5 | CID005361323 | |
| Drug | Meprobamate | 3.43e-06 | 6 | 128 | 3 | DB00371 | |
| Drug | Flunitrazepam | 3.43e-06 | 6 | 128 | 3 | DB01544 | |
| Drug | pyridinium formate | 3.43e-06 | 6 | 128 | 3 | CID013326228 | |
| Drug | Hlnl | 3.46e-06 | 19 | 128 | 4 | CID000122155 | |
| Drug | etifoxine | 3.46e-06 | 19 | 128 | 4 | CID000030768 | |
| Drug | B-Ms | 3.76e-06 | 114 | 128 | 7 | CID000445091 | |
| Drug | hydroxybutyrate | 3.99e-06 | 115 | 128 | 7 | CID000010413 | |
| Drug | lutidinic acid | 5.30e-06 | 21 | 128 | 4 | CID000010365 | |
| Drug | heptachlor epoxide | 5.92e-06 | 46 | 128 | 5 | CID000013930 | |
| Drug | clonazepam | 6.93e-06 | 82 | 128 | 6 | CID000002802 | |
| Drug | PB-3 | 7.32e-06 | 48 | 128 | 5 | CID005289109 | |
| Drug | thiamylal | 8.12e-06 | 49 | 128 | 5 | CID003032285 | |
| Drug | strychnine HCl | 8.67e-06 | 181 | 128 | 8 | CID000005304 | |
| Drug | picrotoxin | 8.67e-06 | 181 | 128 | 8 | CID000031304 | |
| Drug | pentylenetetrazol | 8.96e-06 | 130 | 128 | 7 | CID000005917 | |
| Drug | methohexital | 9.28e-06 | 24 | 128 | 4 | CID000009034 | |
| Drug | HHMD | 9.52e-06 | 8 | 128 | 3 | CID000171068 | |
| Drug | coumalic acid | 9.52e-06 | 8 | 128 | 3 | CID000068141 | |
| Drug | hydroxyallysine | 9.52e-06 | 8 | 128 | 3 | CID000153008 | |
| Drug | potassium | GALR3 HCN3 CAT PTCH1 IGFLR1 CHRNB2 CACNG8 CACNA2D4 SCN2A PKD1 CNTNAP2 SCN9A SV2C ABCG2 SLC7A10 GABRA2 GABRA5 GABRA6 | 1.40e-05 | 1008 | 128 | 18 | CID000000813 |
| Drug | Ethchlorvynol | 1.42e-05 | 9 | 128 | 3 | DB00189 | |
| Drug | AC1Q3ZOL | GABRD GRIA3 PTCH1 CHRNB2 CACNA2D4 PLOD1 GABRA2 GABRA5 GABRA6 | 1.58e-05 | 258 | 128 | 9 | CID000002376 |
| Drug | nipecotic acid | 1.72e-05 | 57 | 128 | 5 | CID000004498 | |
| Drug | indiplon | 1.72e-05 | 57 | 128 | 5 | CID006450813 | |
| Drug | nimodipine | 1.83e-05 | 145 | 128 | 7 | CID000004497 | |
| Drug | AC1Q5UBL | 1.91e-05 | 146 | 128 | 7 | CID000005466 | |
| Drug | ethanol | GABRD ERBB2 GRIA3 CAT APOB F2R CHRNB2 SLC6A2 CACNA2D4 GYS2 SCN9A PLOD2 SOAT1 GABRA2 GABRA5 GABRA6 | 1.93e-05 | 837 | 128 | 16 | CID000000702 |
| Drug | N-methyl-DL-aspartic acid | GABRD GRIA3 IDS PTCH1 CHRNB2 CACNG8 CACNA2D4 PKD1 SCN9A NTN1 PLOD1 GABRA2 GABRA5 GABRA6 | 1.97e-05 | 655 | 128 | 14 | CID000004376 |
| Drug | Secobarbital | 2.02e-05 | 10 | 128 | 3 | DB00418 | |
| Drug | Chlordiazepoxide | 2.02e-05 | 10 | 128 | 3 | DB00475 | |
| Drug | Metharbital | 2.02e-05 | 10 | 128 | 3 | DB00463 | |
| Drug | Pentobarbital | 2.02e-05 | 10 | 128 | 3 | DB00312 | |
| Drug | Talbutal | 2.02e-05 | 10 | 128 | 3 | DB00306 | |
| Drug | Clobazam | 2.02e-05 | 10 | 128 | 3 | DB00349 | |
| Drug | Butalbital | 2.02e-05 | 10 | 128 | 3 | DB00241 | |
| Drug | Butabarbital | 2.02e-05 | 10 | 128 | 3 | DB00237 | |
| Drug | Bromazepam | 2.02e-05 | 10 | 128 | 3 | DB01558 | |
| Drug | Barbituric acid derivative | 2.02e-05 | 10 | 128 | 3 | DB01496 | |
| Drug | Barbital | 2.02e-05 | 10 | 128 | 3 | DB01483 | |
| Drug | Hexobarbital | 2.02e-05 | 10 | 128 | 3 | DB01355 | |
| Drug | Aprobarbital | 2.02e-05 | 10 | 128 | 3 | DB01352 | |
| Drug | Amobarbital | 2.02e-05 | 10 | 128 | 3 | DB01351 | |
| Drug | Heptabarbital | 2.02e-05 | 10 | 128 | 3 | DB01354 | |
| Drug | Butethal | 2.02e-05 | 10 | 128 | 3 | DB01353 | |
| Drug | AC1L1FKW | 2.02e-05 | 10 | 128 | 3 | CID000003281 | |
| Drug | Methylphenobarbital | 2.02e-05 | 10 | 128 | 3 | DB00849 | |
| Drug | Oxazepam | 2.02e-05 | 10 | 128 | 3 | DB00842 | |
| Drug | Primidone | 2.02e-05 | 10 | 128 | 3 | DB00794 | |
| Drug | Midazolam | 2.02e-05 | 10 | 128 | 3 | DB00683 | |
| Drug | Flurazepam | 2.02e-05 | 10 | 128 | 3 | DB00690 | |
| Drug | 5-oxaproline | 2.02e-05 | 10 | 128 | 3 | CID003082452 | |
| Drug | bacoside A | 2.02e-05 | 10 | 128 | 3 | ctd:C500175 | |
| Drug | clobazam | 2.03e-05 | 29 | 128 | 4 | CID000002789 | |
| Drug | AC1L1BIT | 2.21e-05 | 60 | 128 | 5 | CID000001457 | |
| Drug | 3-isothujone | 2.33e-05 | 30 | 128 | 4 | CID000011027 | |
| Drug | orlistat | 2.40e-05 | 61 | 128 | 5 | ctd:C055122 | |
| Drug | methanethiosulfonate | 2.57e-05 | 103 | 128 | 6 | CID004188587 | |
| Drug | gamma-Aminobutyric Acid | 2.60e-05 | 62 | 128 | 5 | ctd:D005680 | |
| Drug | Thiopental | 2.77e-05 | 11 | 128 | 3 | DB00599 | |
| Drug | Alprazolam | 2.77e-05 | 11 | 128 | 3 | DB00404 | |
| Drug | fosazepam | 2.77e-05 | 11 | 128 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 2.77e-05 | 11 | 128 | 3 | CID000027452 | |
| Drug | flutoprazepam | 2.77e-05 | 11 | 128 | 3 | CID000003400 | |
| Drug | Arfendazam | 2.77e-05 | 11 | 128 | 3 | CID000065803 | |
| Drug | Temazepam | 2.77e-05 | 11 | 128 | 3 | DB00231 | |
| Drug | Lorazepam | 2.77e-05 | 11 | 128 | 3 | DB00186 | |
| Drug | NSC55260 | 2.77e-05 | 11 | 128 | 3 | CID005356351 | |
| Drug | camazepam | 2.77e-05 | 11 | 128 | 3 | CID000037367 | |
| Drug | Phenobarbital | 2.77e-05 | 11 | 128 | 3 | DB01174 | |
| Drug | Bu-1014 | 2.77e-05 | 11 | 128 | 3 | CID015942721 | |
| Drug | Zapizolam | 2.77e-05 | 11 | 128 | 3 | CID000068832 | |
| Drug | Reclazepam | 2.77e-05 | 11 | 128 | 3 | CID003052777 | |
| Drug | iclazepam | 2.77e-05 | 11 | 128 | 3 | CID000068777 | |
| Drug | menitrazepam | 2.77e-05 | 11 | 128 | 3 | CID000189875 | |
| Drug | Triazolam | 2.77e-05 | 11 | 128 | 3 | DB00897 | |
| Drug | Serin hydrazid | 2.77e-05 | 11 | 128 | 3 | CID000041637 | |
| Drug | sulazepam | 2.77e-05 | 11 | 128 | 3 | CID000017931 | |
| Drug | YM872 | 2.77e-05 | 11 | 128 | 3 | CID000148200 | |
| Drug | elfazepam | 2.77e-05 | 11 | 128 | 3 | CID000065445 | |
| Drug | Clorazepate | 2.77e-05 | 11 | 128 | 3 | DB00628 | |
| Drug | triflubazam | 2.77e-05 | 11 | 128 | 3 | CID000031157 | |
| Drug | uldazepam | 2.77e-05 | 11 | 128 | 3 | CID000034274 | |
| Drug | gidazepam | 2.77e-05 | 11 | 128 | 3 | CID000121919 | |
| Drug | fletazepam | 2.77e-05 | 11 | 128 | 3 | CID000036834 | |
| Drug | barbiturate | 3.03e-05 | 32 | 128 | 4 | CID000006211 | |
| Drug | beta-carboline | 3.04e-05 | 64 | 128 | 5 | CID000064961 | |
| Drug | mibefradil | 3.04e-05 | 64 | 128 | 5 | CID000060662 | |
| Drug | midazolam | 3.19e-05 | 107 | 128 | 6 | CID000004192 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.68e-08 | 9 | 124 | 4 | C3502809 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.12e-08 | 10 | 124 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.12e-08 | 10 | 124 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.43e-07 | 12 | 124 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | CNTN4 GALR3 CAT SERINC2 CNTN6 SLC6A2 CNTNAP2 GABRA2 GABRA5 GABRA6 | 2.12e-07 | 268 | 124 | 10 | C0001973 |
| Disease | Polycystic Kidney, Autosomal Dominant | 5.97e-06 | 9 | 124 | 3 | C0085413 | |
| Disease | Tremor | 1.17e-05 | 11 | 124 | 3 | C0040822 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.75e-05 | 2 | 124 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.01e-05 | 13 | 124 | 3 | C0751122 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 2.18e-05 | 39 | 124 | 4 | DOID:12930 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.58e-05 | 152 | 124 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | B Virus Infection | 5.24e-05 | 3 | 124 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 5.24e-05 | 3 | 124 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 5.24e-05 | 3 | 124 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 5.24e-05 | 3 | 124 | 2 | C0019372 | |
| Disease | Autosomal dominant polycystic kidney disease | 5.24e-05 | 3 | 124 | 2 | cv:C0085413 | |
| Disease | epilepsy (implicated_via_orthology) | 6.76e-05 | 163 | 124 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Myoclonic Seizures | 7.97e-05 | 104 | 124 | 5 | C4317123 | |
| Disease | Mood Disorders | 7.99e-05 | 168 | 124 | 6 | C0525045 | |
| Disease | heart rate response to recovery post exercise | 9.88e-05 | 57 | 124 | 4 | EFO_0009185 | |
| Disease | Epilepsy | 9.96e-05 | 109 | 124 | 5 | C0014544 | |
| Disease | secondary hyperparathyroidism (biomarker_via_orthology) | 1.05e-04 | 4 | 124 | 2 | DOID:12466 (biomarker_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.05e-04 | 22 | 124 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.22e-04 | 261 | 124 | 7 | C0004352 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.39e-04 | 117 | 124 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Bipolar Disorder | 1.92e-04 | 477 | 124 | 9 | C0005586 | |
| Disease | Sensory Neuropathy, Hereditary | 2.60e-04 | 6 | 124 | 2 | C0699739 | |
| Disease | Hyporeflexia | 2.60e-04 | 6 | 124 | 2 | C0151888 | |
| Disease | Familial benign neonatal epilepsy | 2.60e-04 | 6 | 124 | 2 | C0220669 | |
| Disease | Seizure, Febrile, Simple | 3.63e-04 | 7 | 124 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 3.63e-04 | 7 | 124 | 2 | C0751057 | |
| Disease | Polycystic kidney disease, type 2 | 3.63e-04 | 7 | 124 | 2 | C2751306 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 3.67e-04 | 80 | 124 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 4.03e-04 | 82 | 124 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 4.03e-04 | 82 | 124 | 4 | C0751111 | |
| Disease | Aura | 4.03e-04 | 82 | 124 | 4 | C0236018 | |
| Disease | Autism Spectrum Disorders | 4.62e-04 | 85 | 124 | 4 | C1510586 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 4.82e-04 | 8 | 124 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 4.82e-04 | 8 | 124 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 4.82e-04 | 8 | 124 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 4.82e-04 | 8 | 124 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 4.82e-04 | 8 | 124 | 2 | C0438414 | |
| Disease | Intestinal Diseases | 4.82e-04 | 8 | 124 | 2 | C0021831 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 4.82e-04 | 8 | 124 | 2 | C0887850 | |
| Disease | Myoclonic Absence Epilepsy | 4.82e-04 | 8 | 124 | 2 | C0393703 | |
| Disease | lysine measurement | 5.07e-04 | 37 | 124 | 3 | EFO_0005002 | |
| Disease | Fatty Liver | 5.27e-04 | 88 | 124 | 4 | C0015695 | |
| Disease | Steatohepatitis | 5.27e-04 | 88 | 124 | 4 | C2711227 | |
| Disease | blood molybdenum measurement | 5.49e-04 | 38 | 124 | 3 | EFO_0007582 | |
| Disease | Tremor, Neonatal | 6.19e-04 | 9 | 124 | 2 | C0235843 | |
| Disease | Febrile Convulsions | 6.19e-04 | 9 | 124 | 2 | C0009952 | |
| Disease | Tremor, Perioral | 6.19e-04 | 9 | 124 | 2 | C0235078 | |
| Disease | Nerve Tremors | 6.19e-04 | 9 | 124 | 2 | C0235083 | |
| Disease | Tremor, Limb | 6.19e-04 | 9 | 124 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 6.19e-04 | 9 | 124 | 2 | C0235082 | |
| Disease | Senile Tremor | 6.19e-04 | 9 | 124 | 2 | C0149840 | |
| Disease | Pill Rolling Tremor | 6.19e-04 | 9 | 124 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 6.19e-04 | 9 | 124 | 2 | C0751565 | |
| Disease | Action Tremor | 6.19e-04 | 9 | 124 | 2 | C0234376 | |
| Disease | Passive Tremor | 6.19e-04 | 9 | 124 | 2 | C0234377 | |
| Disease | Static Tremor | 6.19e-04 | 9 | 124 | 2 | C0234378 | |
| Disease | Resting Tremor | 6.19e-04 | 9 | 124 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 6.19e-04 | 9 | 124 | 2 | C0234372 | |
| Disease | Fine Tremor | 6.19e-04 | 9 | 124 | 2 | C0234373 | |
| Disease | Coarse Tremor | 6.19e-04 | 9 | 124 | 2 | C0234374 | |
| Disease | Massive Tremor | 6.19e-04 | 9 | 124 | 2 | C0234375 | |
| Disease | Persistent Tremor | 6.19e-04 | 9 | 124 | 2 | C0234370 | |
| Disease | Continuous Tremor | 6.19e-04 | 9 | 124 | 2 | C0234371 | |
| Disease | Darkness Tremor | 6.19e-04 | 9 | 124 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 6.19e-04 | 9 | 124 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 6.19e-04 | 9 | 124 | 2 | C0040827 | |
| Disease | Myoclonic Epilepsy | 6.19e-04 | 9 | 124 | 2 | C0014550 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.21e-04 | 447 | 124 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Neurodevelopmental Disorders | 6.50e-04 | 93 | 124 | 4 | C1535926 | |
| Disease | Epilepsy, Myoclonic, Infantile | 7.71e-04 | 10 | 124 | 2 | C0917800 | |
| Disease | sleep time | 7.71e-04 | 10 | 124 | 2 | EFO_0005274 | |
| Disease | Generalized seizures | 8.86e-04 | 101 | 124 | 4 | C0234533 | |
| Disease | Clonic Seizures | 8.86e-04 | 101 | 124 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 8.86e-04 | 101 | 124 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 8.86e-04 | 101 | 124 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 8.86e-04 | 101 | 124 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 8.86e-04 | 101 | 124 | 4 | C0751123 | |
| Disease | Complex partial seizures | 8.86e-04 | 101 | 124 | 4 | C0149958 | |
| Disease | Single Seizure | 8.86e-04 | 101 | 124 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 8.86e-04 | 101 | 124 | 4 | C3495874 | |
| Disease | Visual seizure | 8.86e-04 | 101 | 124 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 8.86e-04 | 101 | 124 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 8.86e-04 | 101 | 124 | 4 | C0422855 | |
| Disease | Gustatory seizure | 8.86e-04 | 101 | 124 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 8.86e-04 | 101 | 124 | 4 | C0422850 | |
| Disease | Olfactory seizure | 8.86e-04 | 101 | 124 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 8.86e-04 | 101 | 124 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 8.86e-04 | 101 | 124 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 8.86e-04 | 101 | 124 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 8.86e-04 | 101 | 124 | 4 | C4317109 | |
| Disease | Absence Seizures | 9.19e-04 | 102 | 124 | 4 | C4316903 | |
| Disease | Convulsions | 9.19e-04 | 102 | 124 | 4 | C4048158 | |
| Disease | Tonic Seizures | 9.19e-04 | 102 | 124 | 4 | C0270844 | |
| Disease | Myoclonic Astatic Epilepsy | 9.40e-04 | 11 | 124 | 2 | C0393702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YYFFLASNWRSAGGV | 721 | Q6ZRH7 | |
| PAFSPAFDNLYYWDQ | 1211 | P04626 | |
| AAAANYTYWAYVPFP | 96 | O71037 | |
| AAAANYTNWAYVPFP | 96 | Q9UKH3 | |
| FNAIATGKYPSWTFY | 266 | P04040 | |
| PGYYYFTFQVLSQWE | 156 | P02745 | |
| GSFAFSGWNFLNYVT | 241 | Q9NS82 | |
| RSFPGSLYYFQLWDH | 176 | Q8IZF6 | |
| EPWYFYLINGFLNFN | 301 | Q9H6U8 | |
| ADEWGENYFLIGPYF | 56 | P54840 | |
| VFWSISYYSSPFAFF | 66 | O95870 | |
| SWLQYFSIPRYGFTA | 566 | Q9UNQ0 | |
| TIGYNVYHSYDLPWF | 111 | O95674 | |
| GELSYAWIFNEYPSY | 151 | Q8IWV2 | |
| IRFFGTTNFAPGYWY | 501 | Q8N3C7 | |
| VPVQFFGGWYFYIQA | 721 | Q04656 | |
| SSFSPEAWLQQYGYL | 31 | P50281 | |
| DYGRTWVPFQFYSTQ | 166 | O95631 | |
| QGPFSYDFSYWARSG | 746 | P69849 | |
| FDFYSRYFAPWVGVA | 211 | P30039 | |
| DDGTFYRFQAPYFWP | 106 | P49758 | |
| YSSYNDSWRFPNPGL | 351 | Q02548 | |
| PFSVIYRYFPGFDWF | 286 | Q8N2K0 | |
| SNFWGALSPDEYYAR | 426 | O60568 | |
| QGPFSYDFSYWARSG | 746 | Q5JPE7 | |
| TWVAYSAFAAHPFLY | 276 | Q9BZJ7 | |
| ANPGWYWASYAVFFA | 136 | Q9BWQ8 | |
| NYFFSPTKVADWFYD | 176 | Q8IYB1 | |
| DFGSTYSPWQYFAHS | 176 | Q16787 | |
| IFQFQLLTSWGDPYY | 1401 | O60303 | |
| QNGLFYDPYWTDSLF | 256 | Q9BXJ5 | |
| PVLFGTFNLVYWATY | 426 | P47869 | |
| AGYWNEYERFVPFSD | 396 | P42263 | |
| FFFTTLGLLYHNWYP | 231 | Q9H3H5 | |
| RNLYYSPDSVEFWAF | 126 | P07098 | |
| IYFFNGPIQFEYSIW | 441 | P45452 | |
| ANPAVTYIYNWAYGF | 141 | Q96FX8 | |
| GEFPVFFFGSKDYYW | 916 | O96028 | |
| QGPFSYDFSYWARSG | 746 | Q15155 | |
| APVFLLRWFYSASDY | 506 | Q9Y2G8 | |
| IADSNYNWFYGPESQ | 311 | Q9UL01 | |
| YNWFYGPESQLVFLD | 316 | Q9UL01 | |
| YLSCYDFWTNAGSPD | 121 | Q8NA19 | |
| FGSYAYPNSEVVYVW | 191 | P31644 | |
| PVAFAGFNLVYWVVY | 426 | Q16445 | |
| SEYFNFDWVTFLGTG | 11 | Q6W3E5 | |
| PAAFAAVNVIYWAAY | 436 | O14764 | |
| QAPQRLSFYSWYGSA | 51 | Q9HCN3 | |
| AGAWIIHPYSDFRFY | 81 | Q9P1Z3 | |
| SLFFGNLYIYFAWQG | 146 | O43934 | |
| WIYAGSANSNFFYAI | 376 | Q9H490 | |
| SNFWGALSPDGYYAR | 426 | O00469 | |
| NYLGNYIPRFWTFET | 251 | Q02809 | |
| PFKISYYFSGSDWQF | 156 | P25116 | |
| LVWYNDSYTSFFGIP | 361 | Q9NQX0 | |
| YGYVNFRFPADAEWA | 61 | Q96DU9 | |
| ITPWQSSFFGFYDAN | 231 | Q9UMR5 | |
| FWFYNYGLSVGAAEL | 736 | Q5VYJ5 | |
| LCFWYGRFAFSPATY | 256 | O60755 | |
| QGFYNGPVSKFWAYA | 101 | Q9H5J4 | |
| DDDFSKWNFYYSPQS | 4016 | P04114 | |
| SYGWSFYFGGLSFIL | 201 | Q8WXS5 | |
| YLFEDDPSVLYFSWH | 181 | Q969S8 | |
| VRDWSFPYEFSYGAD | 216 | Q8WXF7 | |
| YPCAFYGRGFTKNSW | 256 | Q6E213 | |
| AAAANYTYWAYVPFP | 96 | P61570 | |
| AAAANYTYWAYVPFP | 96 | Q69384 | |
| WQYFGSATGFFRIYP | 246 | Q7Z3S7 | |
| NYFSFAAWLFYGLTI | 376 | P82251 | |
| AARYGLPAAWSTFAY | 286 | Q9H665 | |
| YGDNYNWFFLALPTT | 131 | P0DN25 | |
| GDLSYAWTFNDNPLY | 151 | Q9UQ52 | |
| YSFVSANEAPFYLWG | 751 | O43303 | |
| FPKARFASEYGYQSW | 546 | O00462 | |
| FASEYGYQSWPSFST | 551 | O00462 | |
| LFSEVQGPWSFIYYQ | 111 | Q9NWL6 | |
| SWDNNVYFYSIAFGR | 691 | Q92636 | |
| AWENPYTALAFAEYA | 656 | Q9UEF7 | |
| YVGHEVFENYFPFQW | 611 | Q68CP4 | |
| NYWNAASFPNPSSYL | 796 | Q9UHC6 | |
| AAAANYTYWAYVPFP | 96 | Q902F9 | |
| DYRYTVWVGFNPDEF | 496 | P22304 | |
| WFPLFSGYTLDQTYA | 396 | P00395 | |
| SLAWFATGFAYYSLA | 331 | Q8TCC7 | |
| YPAAEVVNFGTWFLF | 301 | Q9UKG4 | |
| GELSYAWIFNEYPSF | 151 | Q9P232 | |
| DTAFDYYVAPDGTWT | 2526 | Q8TE73 | |
| WFSENMFGPDFSFYQ | 4271 | Q8TE73 | |
| YVTGNPAHYLFDWTF | 1316 | P98161 | |
| HFFFFTFYTGYPIWG | 81 | Q96HJ5 | |
| TFYTGYPIWGAVFFC | 86 | Q96HJ5 | |
| APDYYDWGQQTNSFL | 366 | O60478 | |
| WYSTVFNPAFYSVEV | 66 | P59538 | |
| DFPAVTTAQYSFWLY | 1006 | P26640 | |
| YYLFSSFTLNLPWTD | 161 | P23975 | |
| FSVPYFLFQHWATGY | 196 | P35610 | |
| GFPSLFFCQYSADLW | 241 | Q6ZUK4 | |
| FTLSFGYYGLSVWFP | 441 | Q496J9 | |
| SGVFYFSWPNDGSRF | 126 | O15056 | |
| DHLYTFFVQWSPDVY | 701 | Q8NI08 | |
| YQFSEPYFLASLLFW | 1426 | Q5K651 | |
| SYDNYEGSAPNLFVW | 526 | Q14697 | |
| SWLPYDRNISNYFSF | 2421 | Q6ZNJ1 | |
| IYSATVAWYPGFTFL | 406 | Q7Z3Q1 | |
| PSAFYIYLTAWVSND | 916 | Q13635 | |
| NPDYGYTSFDTFSWA | 336 | Q15858 | |
| AYFSRAGFPSWQYQR | 231 | A6NHP3 | |
| WSFLPGNFHFYSTFN | 61 | Q96E52 | |
| RNPNYGYTSFDTFSW | 356 | P35498 | |
| FYSNAVVSYDGSIFW | 131 | P17787 | |
| YQQRFVFPYFDLWGN | 866 | Q8IZF2 | |
| PEEFNFASYVLDYWA | 46 | Q08AH1 | |
| EFFYSYWTGLLRPDS | 191 | Q8NC01 | |
| ARLGTYPDWFFFCSF | 151 | Q8WUD6 | |
| YNSFSFPGQAARYPW | 486 | O95628 | |
| PFESWQYLYAFQLNS | 161 | Q9NYW4 | |
| VVAYFLSWGPYNFTL | 231 | P46094 | |
| GFWILVFLGSYYNSS | 376 | Q96F44 | |
| NYSFFFWLPFYLSNN | 306 | Q8NCC5 | |
| AYFSRAGFPSWQYQR | 231 | Q495Y8 | |
| AYFSRAGFPSWQYQR | 231 | A6NIY4 | |
| AYFSRAGFPSWQYQR | 231 | P0CI01 | |
| SQSFFWYRQYSGKSP | 51 | A0A075B6T6 | |
| NYGYTSFDTFSWAFL | 361 | Q99250 | |
| FNYVFLISWAFALPY | 961 | Q9H5I5 | |
| FSVGNFFASWYTLIP | 81 | Q86WB7 | |
| PNYGYTSFDTFSWAF | 346 | Q9UQD0 | |
| LTAYVLCWAPFYGFT | 281 | Q8NFJ6 | |
| GDFPVFFFGSHDYYW | 996 | Q9BZ95 | |
| NYFSFSYWFFVGLSV | 391 | Q92536 | |
| HWLSSAYTQFAVPYF | 71 | Q71RH2 | |
| AYDWEFFSVGPYSFL | 476 | Q8WU66 | |
| QYGDWFSYDGSPRAQ | 446 | Q8NHP8 | |
| EILFFLNGWYNATYF | 21 | Q9P0N5 | |
| TAVEYAPDYQSFWTF | 1426 | O60293 | |
| IPFSSADYWSNYEFH | 1826 | O60293 | |
| GAFYIPDGSFTNIWF | 146 | Q96SA4 | |
| VSNAYNFFWYLHFPG | 51 | A0A0B4J234 | |
| LYFPSGSQYDAIWEN | 46 | Q5VZ52 | |
| SRADGPWEPYQFYSA | 151 | Q9Y6N6 | |
| AAGYPSRWAYHDFFN | 691 | Q9ULV0 |